РАЗВИТИЕ РЫНКА ЛЕКАРСТВЕННЫХ ПРЕПАРАТОВ В РОССИИ ДЛЯ ЛЕЧЕНИЯ РЕДКИХ (ОРФАННЫХ) ЗАБОЛЕВАНИЙ В СОВРЕМЕННЫХ УСЛОВИЯХ

Abstract

As the world’s population grows, so does the proportion of people with rare (orphan) diseases. The complexity of the study, the frequency of rare mutations and the difficulty in making such diagnoses complicate the processes of creating and distributing drugs, and therefore increases their cost. The aim of this work is to study the possibilities of developing the market for drugs for orphan diseases in Russia. To develop this goal, the scientific article also analyzes the economic efficiency of state mechanisms for stimulating the creation and distribution of medicines for rare diseases, compares private and public investments in the industry under study, and also conducts an intercountry comparison on the qualitative and quantitative distribution of these drugs in the territory of developed countries and Russia. In the article, the authors use Russian and foreign state and independent statistical collections, opinions and assessments of industry experts, data from manufacturing companies and distributors of orphan drugs, as well as the regulatory framework and state strategies for the development of the drug market in the Russian Federation.